Pages that link to "Q45873395"
Jump to navigation
Jump to search
The following pages link to Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. (Q45873395):
Displaying 50 items.
- Consensus recommendations for the diagnosis and treatment of acquired hemophilia A (Q21202147) (← links)
- Rituximab for eradicating inhibitors in people with acquired haemophilia A (Q24186862) (← links)
- Rituximab for eradicating inhibitors in people with acquired haemophilia A (Q26471152) (← links)
- The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A (Q26778199) (← links)
- Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. (Q33373912) (← links)
- Treatment with rituximab in benign and malignant hematologic disorders in children (Q33374660) (← links)
- Rituximab in the treatment of autoimmune haematological disorders (Q33378854) (← links)
- Investigational drugs in thrombotic thrombocytopenic purpura. (Q33395696) (← links)
- Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP. (Q33402349) (← links)
- Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice (Q34157402) (← links)
- Acquired hemophilia: a case report and review of the literature (Q34416230) (← links)
- Rituximab in the treatment of high responding inhibitors in severe haemophilia A. (Q34651588) (← links)
- Case report of an acquired factor XIII inhibitor: diagnosis and management. (Q34703713) (← links)
- Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver (Q35848563) (← links)
- Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice (Q35849770) (← links)
- Successful Long Term Eradication of Factor VIII Inhibitor in Patients with Acquired Haemophilia A in Saudi Arabia (Q35910932) (← links)
- Inhibitors in congenital coagulation disorders (Q35937076) (← links)
- Rituximab for autoimmune haemophilia: a proposed treatment algorithm (Q36014987) (← links)
- Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). (Q36079810) (← links)
- Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B. (Q36085401) (← links)
- Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature (Q36187312) (← links)
- Extracorporeal Treatment for the Acute und Long-Term Outcome of Patients with Life-Threatening Acquired Hemophilia (Q36210343) (← links)
- Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety (Q36283844) (← links)
- Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors (Q36291064) (← links)
- Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature (Q36462009) (← links)
- The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. (Q36480548) (← links)
- Rituximab in the treatment of acquired hemophilia (Q36492909) (← links)
- Acquired hemophilia A. (Q36497382) (← links)
- B lymphocytes as therapeutic targets in systemic lupus erythematosus (Q36653646) (← links)
- A Hematological Menace: Multiple Venous Thrombosis Complicated by Acquired Factor VIII Deficiency. (Q36776568) (← links)
- Treatment of acquired hemophilia A. (Q36802699) (← links)
- Haemophilia therapies (Q36810282) (← links)
- International workshop on immune tolerance induction: consensus recommendations (Q36861097) (← links)
- B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family (Q36897408) (← links)
- Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature (Q36958165) (← links)
- Autoimmune hemophilia at rescue (Q37146026) (← links)
- International recommendations on the diagnosis and treatment of patients with acquired hemophilia A (Q37146064) (← links)
- Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome (Q37176491) (← links)
- Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature review (Q37190518) (← links)
- Systemic Therapy In Acquired Haemophilia - A Single Institute Experience (Q37272322) (← links)
- B-cell and T-cell epitopes in anti-factor VIII immune responses (Q37382199) (← links)
- Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives (Q37382208) (← links)
- Diagnosis, laboratory aspects and management of acquired hemophilia A. (Q37734945) (← links)
- Postoperative Bleeding in an Elderly Patient From Acquired Factor V Inhibitor: Rapid Response to Immunosuppressive Therapy (Q37834917) (← links)
- Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders. (Q37843939) (← links)
- Factor VIII inhibitors: a 50-year perspective (Q37876956) (← links)
- Bleeding in the patient with a malignancy: is it an acquired factor VIII inhibitor? (Q37896539) (← links)
- Management of acquired haemophilia A. (Q37903945) (← links)
- Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature (Q37968506) (← links)
- How I manage patients with acquired haemophilia A. (Q38078394) (← links)